Staging lymph nodes and blood at diagnosis in mycosis fungoides identifies patients at increased risk of progression to advanced stage: A retrospective cohort study.
Pamela Blair AllenAshley A McCook-VealJeffrey M SwitchenkoDarina M PaulinoTim NiyogusabaKatelin M BairdErica S TarabadkarMary Jo LechowiczPublished in: Cancer (2022)
Staging and baseline laboratory assessments with imaging, peripheral blood flow cytometry, TCR data, and LDH in patients who have newly diagnosed MF may identify those who are at risk for progression to advanced stage.
Keyphrases
- newly diagnosed
- lymph node
- flow cytometry
- peripheral blood
- end stage renal disease
- ejection fraction
- pet ct
- high resolution
- prognostic factors
- genome wide
- regulatory t cells
- gene expression
- electronic health record
- neoadjuvant chemotherapy
- immune response
- early stage
- dna methylation
- machine learning
- dendritic cells
- patient reported outcomes
- photodynamic therapy